z-logo
open-access-imgOpen Access
Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction
Author(s) -
Konstantinos Malliaras,
Rachel Smith,
Hideaki Kanazawa,
Kristine Yee,
Jeffrey Seinfeld,
Eleni Tseliou,
James Dawkins,
Michelle Kreke,
Ke Cheng,
Daniel Luthringer,
ChakSum Ho,
Agnieszka Blusztajn,
Ileana Valle,
Supurna Chowdhury,
Raj Makkar,
Rohan Dharmakumar,
Debiao Li,
Linda Marbán,
Eduardo Marbán
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.002863
Subject(s) - medicine , magnetic resonance imaging , myocardial infarction , cell therapy , cardiology , ventricular remodeling , stem cell , regeneration (biology) , regenerative medicine , stem cell therapy , pathology , transplantation , radiology , biology , genetics , microbiology and biotechnology
Magnetic resonance imaging (MRI) in the CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction (CADUCEUS) trial revealed that cardiosphere-derived cells (CDCs) decrease scar size and increase viable myocardium after myocardial infarction (MI), but MRI has not been validated as an index of regeneration after cell therapy. We tested the validity of contrast-enhanced MRI in quantifying scarred and viable myocardium after cell therapy in a porcine model of convalescent MI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom